Crommelin, Daan J.A.
Crommelin, D. J. A. (Daan J. A.)
Crommelin, Daan J. A. 1948-
Crommelin, Daan (Daniel Jan Anne), biofarmaceut, 1948-
Crommelin, Daan, 1948-
Daan Crommelin Nizozemský profesor farmakologie, specializace biofarmacie. Publikuje též v angličtině.
VIAF ID: 93504865 ( Personal )
Permalink: http://viaf.org/viaf/93504865
Preferred Forms
- 200 _ | ‡a Crommelin ‡b Daan J. A.
-
- 100 1 _ ‡a Crommelin, D. J. A. ‡q (Daan J. A.)
-
-
- 100 1 _ ‡a Crommelin, D. J. A. ‡q (Daan J. A.)
- 100 1 _ ‡a Crommelin, Daan J. A.
-
- 100 1 _ ‡a Crommelin, Daan J. A.
-
-
- 100 1 _ ‡a Crommelin, Daan J. A. ‡d 1948-
-
- 100 1 _ ‡a Crommelin, Daan J.A.
-
-
-
- 100 0 _ ‡a Daan Crommelin ‡c Nizozemský profesor farmakologie, specializace biofarmacie. Publikuje též v angličtině.
4xx's: Alternate Name Forms (16)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
American Association of Pharmaceutical Scientists advances in the pharmaceutical sciences series | |
Biosimilars, generic versions of the first generation of therapeutic proteins: do they exist? | |
Equivalence of complex drug products : scientific and regulatory challenges | |
Equivalence of glatiramer acetate products : challenges in assessing pharmaceutical equivalence and critical clinical performance attributes | |
From clone to clinic | |
In vitro and ex vivo test systems to rationalize drug design and delivery European symposium, Paris, 13 and 14 December 1993 | |
In vitro release studies on drugs suspended in non-polar media : the release of sodium chloride, paracetamol and chloramphenicol from suspensions in liquid paraffin | |
Methods for structural analysis of protein pharmaceuticals / Wim Jiskoot, Daan J.A. Crommelin. | |
Networking in Pharmaceutical Sciences programme, abstracts book, presentations | |
Nieuwe wegen in de farmaceutische wetenschappen | |
Non-Biological Complex Drugs : The Science and the Regulatory Landscape | |
Pharmaceutical Biotechnology Fundamentals and Applications | |
Pharmaceutical evaluation of biosimilars: important differences from generic low-molecular-weight pharmaceuticals | |
Physical methods to characterize pharmaceutical proteins | |
Równoważność produktów zawierających octan glatirameru : problemy z oceną równoważności farmaceutycznej i kluczowe właściwości działania klinicznego | |
Topics in pharmaceutical sciences 1991 proceedings of the 51st International Congress of Pharmaceutical Sciences of F.I.P., held in Washington D.C., USA, 1 - 6 September 1991 |